Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 11113 - 11120 of 11616 results
Regulations Issued for Remote Participation in Meetings Subject to the Massachusetts Open Meeting Law
December 14, 2011| Blog| Viewpoint
Attention HIPAA Covered Entities: Keep an Eye on Your Mailbox....
December 14, 2011| Blog| Viewpoint
California's New Wage Theft Protection Act- Happy New Year to California Employers
December 13, 2011| Blog| Viewpoint
The PROTECT IP ACT and the STOP ONLINE PIRACY ACT (SOPA): New Solutions to Stop Online Infringement and Piracy
December 12, 2011| Blog| Viewpoint
The New York Wage Theft Prevention Act's Annual Pay Notice Deadline is Just Around the Corner
December 12, 2011| Blog| Viewpoint
Longer may not always be better: Congressmen question Facebook's prolix privacy policy
December 12, 2011| Blog| Viewpoint
ML Strategies Posts Weekly Health Care Reform Update, December 5, 2011
December 6, 2011| Blog| Viewpoint
Trademark Enforcement, Trademark "Bullies" and Social Media
December 5, 2011| Blog| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.